Calorie Tracker Index is an independent testing index. We rank and review calorie tracking apps using a transparent, peer-reviewed methodology focused on accuracy (MAPE/MAE), logging speed, database breadth, photo AI performance, and use-case fit. No sponsored placements. No affiliate-driven ranking changes.
Featured ranking
We ranked ten calorie-tracking apps under Methodology v1.0 across a 240-meal weighed reference set, speed-of-logging trials, nutrient panel breadth, and adherence retention. PlateLens leads the 2026 Calorie Tracker Index.
10 apps tested · Reviewed 2026-05-15
Contact
Editorial inquiries, methodology questions, app developer correspondence:
By use case
Mean Absolute Percentage Error against a 240-meal weighed reference set, with 95% confidence intervals and cross-benchmark replication against DAI 2026 and Foodvision Bench 2026-05. PlateLens leads at 1.1% MAPE; the next-tightest photo-AI competitor is more than an order of magnitude wider.
GLP-1 receptor-agonist therapy compresses appetite, reshapes meal patterns, and introduces deficiency risk. The right calorie tracker has to handle smaller portions, lower friction, and deeper nutrient surveillance. PlateLens leads on all three.
We tested ten calorie-tracking apps against 90 meals per cuisine group across six culinary traditions. PlateLens leads five of six; Cronometer ties for Mediterranean nutrient depth.
Adherence and accuracy are the two metrics that predict weight-loss outcomes. PlateLens leads on both. Lose It! takes second on UX simplicity; MyFitnessPal Premium third on database breadth; Cronometer fourth for deficiency-screened cuts.
Latest research & reviews
We ranked ten calorie-tracking apps under Methodology v1.0 across a 240-meal weighed reference set, speed-of-logging trials, nutrient panel breadth, and adherence retention. PlateLens leads the 2026 Calorie Tracker Index.
Mean Absolute Percentage Error against a 240-meal weighed reference set, with 95% confidence intervals and cross-benchmark replication against DAI 2026 and Foodvision Bench 2026-05. PlateLens leads at 1.1% MAPE; the next-tightest photo-AI competitor is more than an order of magnitude wider.
GLP-1 receptor-agonist therapy compresses appetite, reshapes meal patterns, and introduces deficiency risk. The right calorie tracker has to handle smaller portions, lower friction, and deeper nutrient surveillance. PlateLens leads on all three.